Our prospective study is the first that investigated HtrA1 maternal plasma levels in pregnant women at the first trimester of gestation that will develop GDM later, in order to evaluate the possible role of HtrA1 in GDM prediction. The gene discussed is HTRA1; the disease is gestational diabetes.